Felpreva
emodepside / praziquantel / tigolaner
Table of contents
Overview
Felpreva is an antiparasitic medicine used to treat cats that have, or that are at risk from, mixed parasitic infestations/infections (caused by more than one parasite). It contains the active substances tigolaner, emodepside and praziquantel.
Authorisation details
Product details | |
---|---|
Name |
Felpreva
|
Agency product number |
EMEA/V/C/005464
|
Active substance |
|
International non-proprietary name (INN) or common name |
|
Species |
Cats
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QP52AA51
|
Publication details | |
---|---|
Marketing-authorisation holder |
Vétoquinol SA
|
Date of issue of marketing authorisation valid throughout the European Union |
11/11/2021
|
Contact address |
Magny-Vernois
F-70 200 Lure France |
Product information
Felpreva - EMEA/V/C/005464 -
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Anthelmintics
Therapeutic indication
For cats with, or at risk from, mixed parasitic infestations.
The veterinary medicinal product is exclusively indicated when ectoparasites, cestodes and nematodes are targeted at the same time.